BridgeMD
New treatment option for Age-Related Macular Degeneration
Official title Photobiomodulation in Dry Age Related Macular Degeneration
ClinicalTrials.gov ID: NCT06046118
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate effects of consecutive Yellow and Red Light Emitting Diode photobiomodulation in dry age-related macular degeneration (AMD). The main questions it aims to answer are: Is Yellow and Red Light Emitting Diode photobiomodulation effective in decreasing drusen volume in patients affected by dry AMD?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- BCVA ETDRS \> 40 L ETDRS at 4 meters
- Diagnosis of DRY AMD AREDS grade 2-3
- Ability to communicate well with the investigator and able to understand and comply with the requirements of the study
You likely can't join if
- Concomitant epilepsy
- Neurological diseases
- Psychiatric pathologies
- Herpes virus infections
- Dense cataract
- Pregnancy
See the full eligibility criteria
- BCVA ETDRS \> 40 L ETDRS at 4 meters
- Diagnosis of DRY AMD AREDS grade 2-3
- Ability to communicate well with the investigator and able to understand and comply with the requirements of the study
- Concomitant epilepsy
- Neurological diseases
- Psychiatric pathologies
- Herpes virus infections
- Dense cataract
- Pregnancy
- Other significant ocular and/or retinal diseases
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
- Ferrara, Italy
- Naples, Italy
- Torino, Italy
- Ankara, Turkey (Türkiye)
- Koç, Turkey (Türkiye)
- Taunton, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France; Ferrara, Italy; Naples, Italy; Torino, Italy; Ankara, Turkey (Türkiye); Koç, Turkey (Türkiye) and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.